Vera Therapeutics Inc.
VERA | NASDAQ
$35.91
+$1.66 (+4.85%)
Sep 22, 2026, 1:36 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 256K | -1.13M | n/a | 563K | n/a | n/a | n/a | n/a | -952K | -635K | n/a | n/a | -506K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -256K | 1.13M | n/a | -563K | n/a | n/a | n/a | n/a | 952K | 635K | n/a | n/a | 506K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -112.49M | -125.13M | -94.21M | -83.93M | -80.14M | -57.19M | -48.91M | -49.8M | -37.34M | -31.11M | -27.03M | -21.76M | -21.97M | -31.26M | -33.58M | -25.24M | -15.06M | -17.02M | -16.59M | -7.25M | -5.85M | -4.72M |
Interest Income | 5.35M | 6.36M | 18.96M | 5.74M | 6.32M | 6.91M | 6.66M | 4.76M | 5.1M | 4.19M | 1.96M | 2.16M | 2.24M | 1.62M | 894K | 567K | 263K | 26K | 6K | 5K | 2K | 2K |
Pretax Income | -109.47M | -121.03M | -91.1M | -80.29M | -76.53M | -51.69M | -43.42M | -46.63M | -33.71M | -28.38M | -25.65M | -20.1M | -20.16M | -30.07M | -32.44M | -24.68M | -14.85M | -17.09M | -16.85M | -7.61M | -3.44M | -4.71M |
Net Income | -109.47M | -121.03M | -91.1M | -80.29M | -76.53M | -51.69M | -43.43M | -46.63M | -33.71M | -28.38M | -25.66M | -20.1M | -20.16M | -30.07M | -32.44M | -24.68M | -14.85M | -17.09M | -16.85M | -7.61M | -3.44M | -4.71M |
Selling & General & Admin | 52.41M | 39.12M | 34.9M | 27.46M | 21.95M | 15.92M | 15.57M | 9.49M | 8.03M | 7.4M | 5.71M | 5.66M | 5.74M | 6.15M | 6.91M | 5.59M | 4.95M | 4.47M | 3.83M | 3.69M | 2.61M | 1.78M |
Research & Development | 60.08M | 86.01M | 59.56M | 56.47M | 58.08M | 41.28M | 33.35M | 40.31M | 29.31M | 24.67M | 21.95M | 16.1M | 16.23M | 25.61M | 26.68M | 19.66M | 10.11M | 12.55M | 12.75M | 3.56M | 3.24M | 2.93M |
Other Expenses | n/a | n/a | 879K | n/a | -444K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 112.49M | 125.13M | 95.33M | 83.93M | 79.58M | 57.19M | 48.91M | 49.8M | 37.34M | 32.06M | 27.66M | 21.76M | 21.97M | 31.76M | 33.58M | 25.24M | 15.06M | 17.02M | 16.59M | 7.25M | 5.85M | 4.72M |
Interest Expense | 1.85M | 1.82M | 5.63M | 1.96M | 1.87M | 1.79M | 1.87M | 1.94M | 1.91M | 1.91M | 1.06M | 943K | 914K | 874K | 599K | 147K | 128K | 118K | 20K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | 5.71M | n/a | 1.34M | n/a | n/a | n/a | -517K | -532K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 112.49M | 125.13M | 94.21M | 83.93M | 80.14M | 57.19M | 48.91M | 49.8M | 37.34M | 31.11M | 27.03M | 21.76M | 21.97M | 31.26M | 33.58M | 25.24M | 15.06M | 17.02M | 16.59M | 7.25M | 5.85M | 4.72M |
Income Tax Expense | n/a | n/a | -1K | n/a | n/a | n/a | 1K | n/a | n/a | n/a | 1K | n/a | n/a | n/a | 1K | n/a | n/a | n/a | 1K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 71.84M | 71.48M | 64.23M | 63.85M | 63.79M | 63.67M | 54.9M | 54.9M | 54.73M | 50.97M | 44.45M | 44.36M | 44.27M | 37.67M | 27.8M | 27.22M | 27.08M | 24.23M | 21.28M | 21.27M | 10.5M | 20.48M |
Shares Outstanding (Diluted) | 71.84M | 71.48M | 64.23M | 63.85M | 63.79M | 63.67M | 54.9M | 54.9M | 54.73M | 50.97M | 44.45M | 44.36M | 44.27M | 37.67M | 27.8M | 27.22M | 27.08M | 24.23M | 21.28M | 21.27M | 10.5M | 20.48M |
EPS (Basic) | -1.52 | -1.69 | -1.39 | -1.26 | -1.20 | -0.81 | -0.85 | -0.85 | -0.62 | -0.56 | -0.58 | -0.45 | -0.46 | -0.79 | -1.17 | -0.89 | -0.55 | -0.71 | -0.79 | -0.36 | -0.33 | -0.23 |
EPS (Diluted) | -1.52 | -1.69 | -1.39 | -1.26 | -1.20 | -0.81 | -0.85 | -0.85 | -0.62 | -0.56 | -0.58 | -0.45 | -0.46 | -0.79 | -1.17 | -0.89 | -0.55 | -0.71 | -0.79 | -0.36 | -0.33 | -0.23 |
EBITDA | -107.49M | -118.95M | -85.34M | -78.2M | -74.09M | -49.82M | -41.5M | -44.67M | -30.3M | -26.47M | -27.16M | -19.16M | -18.73M | -29.7M | -31.8M | -24.53M | -14.73M | -16.96M | -16.79M | -7.55M | -3.39M | -4.68M |
EBIT | -107.63M | -119.21M | -85.47M | -78.33M | -74.66M | -49.9M | -41.55M | -44.7M | -31.8M | -26.48M | -26.53M | -19.16M | -19.25M | -29.2M | -31.84M | -24.53M | -14.73M | -16.97M | -16.83M | -7.61M | -3.44M | -4.71M |
Depreciation & Amortization | 132K | 256K | 135K | 129K | 563K | 85K | 55K | 24K | 1.5M | 11K | -635K | 6K | 517K | -506K | 44K | n/a | n/a | 9K | 32K | 59K | 50K | 35K |
Add to Watchlist
Select watchlists to add or remove VERA